Capital A Partners Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Capital A Partners has acquired 1 company.

Capital A Partners’ most common sectors for investment are manufacturing (15%) and business services (10%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (55%) and divestiture (15%). In total, Capital A Partners has invested in 7 different countries. Its largest (disclosed) acquisition occurred in 2005 when it acquired Loparex Group for $259M.

In the last 3 years, Capital A Partners has exited 4 companies. The Firm’s most common exit type is trade sale (49%). Capital A Partners’ largest (disclosed) exit occurred in 2005 when it sold GlycArt Biotechnology AG for $244M.

Join Mergr to view Capital A Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity69
    • M&A Buy Activity40
    • M&A Sell Activity29
  • Total Sectors Invested 23
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 32
  • M&A Advisors 3

Capital A Partners

Gustav Mahlerlaan 10,
Amsterdam, 1082 PP
Netherlands,
+31 (0)20 628 1276
www.capitalapartners.nl
info@capitalapartners.nl

ABN AMRO Participaties BV is a private equity firm specializing in management buyouts, management buy-ins, expansion/growth financing, shareholder replacement and turnarounds. ABN targets mid-sized Dutch companies and focuses on acquiring businesses with sustainable positive cash flow and strong market positions. The Firm typically invests in a broad range of industry sectors with an investment of €5 - €30 million per transactions. ABN will not invest in financial services and real estate but will consider both majority and minority ownership positions. ABN AMRO Participaties BV is subsidiary of ABN AMRO Bank NV and is based in Amsterdam.


Investment Criteria

Sectors of Interest: Agriculture, Apparel/Textiles, Business Services, Consumer Products, Distribution, Food, Furniture, Information Technology, Machinery, Manufacturing, Marketing, Medical Products, Retail, Transportation

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Special Situations/Distressed, Acquisition Financing, Add-on Acquisition

Geographic Preferences: Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 5 50
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.2/yr) # 39 - - - 1 - 40
vol $295M $295M
Sell (0.8/yr) # 25 - 2 1 1 - 29
vol $577M $145M $722M
  69

Most Recent M&A

Company Date Value Type
Smart Internet Media BV 2019-10-01 - Buyout (LBO, MBO, MBI)
Hilversum, Netherlands · www.smart-im.nl
Nedac Sorbo B.V. 2019-02-20 - Secondary Buyout
Duiven, Netherlands · www.nedac.com
eVision Industry Software BV 2018-10-30 145M USD Add-on Acquisition
The Hague, Netherlands · www.evision-software.com
Duo-Med Instruments NV 2017-05-10 - Secondary Buyout
Londerzeel, Belarus · www.devroe.com
Vanderlande Industries BV 2017-03-23 - Add-on Acquisition
Veghel, Netherlands · www.vanderlande.com
INCOTEC Group BV 2015-12-01 175M EUR Add-on Acquisition
Enkhuizen, Netherlands · www.incotec.com
Claymount Assemblies BV 2015-07-29 56M EUR Add-on Acquisition
Dinxperlo, Netherlands · www.claymount.com
Acertys Healthcare NV 2015-05-08 - Divestiture
Aartselaar, Belgium
Medvision Healthcare nv 2015-05-08 - Divestiture
Aartselaar, Belgium · www.medvision.be
FMH Medical BV 2015-05-08 - Divestiture
PG Veenendaal, Netherlands · endoscopy.nl
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Humares BV 2006-01-01 IMPACT 2018-02-09 1
Vlissingen, Netherlands · www.humares.com Hasselt, Belgium · www.impact.be
Loparex Group 2005-09-01 Douglas-Hanson Co., Inc. 2006-07-05 1
Apeldoorn, Netherlands · www.loparex.com Hammond, Wisconsin

M&A by Sector

Sector Current # Value All-time # Value
Manufacturing 5 (31%) 259M (100%) 6 (15%) 259M (88%)
Business Services - - 4 (10%) -
Apparel/Textiles - - 2 (5%) -
Consumer Products 1 (6%) - 2 (5%) -
Distribution 1 (6%) - 2 (5%) -
Food - - 2 (5%) -
Healthcare Services 2 (13%) - 2 (5%) -
Life Science 1 (6%) - 2 (5%) -
Medical Products - - 2 (5%) -
Staffing 2 (13%) - 2 (5%) -
Transportation 1 (6%) - 2 (5%) -
Communications - - 1 (3%) 35M (12%)
Chemicals - - 1 (3%) -
Electrical Equipment - - 1 (3%) -
Financial Services - - 1 (3%) -
Machinery - - 1 (3%) -
Marketing 1 (6%) - 1 (3%) -
Media 1 (6%) - 1 (3%) -
Plastics 1 (6%) - 1 (3%) -
Safety/Security - - 1 (3%) -
Software - - 1 (3%) -
Technology Hardware - - 1 (3%) -
Test/Measurement Equipment - - 1 (3%) -
Total 16 $259M 40 $295M

Acquisitions By Geo

State/Country Current # Value All-time # Value
Netherlands 13 (81%) 259M (100%) 31 (78%) 259M (88%)
United Kingdom 1 (6%) - 3 (8%) -
Belgium 2 (13%) - 2 (5%) -
France - - 1 (3%) 35M (12%)
Belarus - - 1 (3%) -
Sweden - - 1 (3%) -
Switzerland - - 1 (3%) -
Domestic 13 (81%) 259M (100%) 31 (78%) 259M (88%)
Cross-border 3 (19%) - 9 (23%) 35M (12%)
Total 16 $259M 40 $295M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 7 (44%) 259M (100%) 22 (55%) 295M (100%)
Divestiture 3 (19%) - 6 (15%) -
Growth Capital 3 (19%) - 4 (10%) -
Secondary Buyout 1 (6%) - 4 (10%) -
Venture 1 (6%) - 2 (5%) -
Consolidation - - 1 (3%) -
Stake Purchase 1 (6%) - 1 (3%) -
Total 16 $259M 40 $295M

Exits by Deal Type

Type Total # Value
Secondary Sale 11 (38%) 102M (14%)
Trade Sale - Public Company 8 (28%) 620M (86%)
Trade Sale 8 (28%) -
Bankruptcy 1 (3%) -
Unknown 1 (3%) -
Total 29 $722M

Top M&A Advisors

Financial Deals
Robert W. Baird & Co., Inc.
1
Corporate Finance in Europe
1
Legal Deals
Loyens & Loeff N.V.
2

Deal Values

buy # Total
$100M to $1B 1 $259M
< $100M 1 $35M
TOTAL $295M
Largest Loparex Group
$259M (2005-09-01)
sell # Total
$100M to $1B 4 $666M
< $100M 1 $56M
TOTAL $722M
Largest GlycArt Biotechnology AG
$244M (2005-07-19)

M&A Connections

Deals %
Acquired from
PE Firm(s)
40%
4 40%
Strategic(s)
60%
6 60%
Exited to
PE Firm(s)
44%
11 44%
Strategic(s)
56%
14 56%

 Subscribe to unlock this and 148,045
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.8K Private Equity Firms
  • 135K M&A Transactions
  • 144K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.